Clinical Trial Update: SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating SU5416 in combination with hormone therapy and radiation for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SU5416 (semaxanib)

Snippet

Sponsor: University of Chicago | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED